Charles River Laboratories International
CRL57
$186.12arrow_drop_down1.01%-$1.91
S&P500
CRL57
$186.12
arrow_drop_down1.01%Performance History
| Key Stats | |
|---|---|
| Open | $183.97 |
| Prev. Close | $187.91 |
| EPS | 7.93 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 181.00 | 189.50 |
| 52 Week Range | 161.65 | 275.00 |
| Ratios | |
|---|---|
| EPS | 7.93 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Charles River Laboratories International (CRL)
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- CEO
- Mr. James C. Foster J.D.
- Headquarters
- Wilmington
- Employees
- 20000
- Exchange
- NYSE
Keep an eye on Charles River Laboratories International
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Charles River Laboratories International 's (CRL) price per share?
The current price per share for Charles River Laboratories International (CRL) is $186.12. The stock has seen a price change of -$1.91 recently, indicating a -1.02% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Charles River Laboratories International (CRL)?
For Charles River Laboratories International (CRL), the 52-week high is $275, which is 47.75% from the current price. The 52-week low is $161.65, the current price is 15.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Charles River Laboratories International (CRL) a growth stock?
Charles River Laboratories International (CRL) has shown an average price growth of -2.21% over the past three years. It has received a score of 21 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Charles River Laboratories International as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Charles River Laboratories International (CRL) stock price performance year to date (YTD)?
As of the latest data, Charles River Laboratories International (CRL) has a year-to-date price change of 0.82%. Over the past month, the stock has experienced a price change of -3.84%. Over the last three months, the change has been -3.55%. Over the past six months, the figure is -11.74%. Looking at a longer horizon, the five-year price change stands at 16.98%.
help
Is Charles River Laboratories International (CRL) a profitable company?
Charles River Laboratories International (CRL) has a net income of $480.37M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 36.39% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.69% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $4.13B, with a revenue growth rate of 3.86%, providing insight into the company's sales performance and growth. The gross profit is $1.5B. Operating income is noted at $617.26M. Furthermore, the EBITDA is $990.36M.
help
What is the market capitalization of Charles River Laboratories International (CRL)?
Charles River Laboratories International (CRL) has a market capitalization of $9.53B. The average daily trading volume is 186.18, indicating the stock's liquidity and investor engagement.